Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Open-label Study of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies
jRCT2080222063Phase 1
- Sponsor
- AstraZeneca
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of olaparib in Non-hematologic malignancy, sponsored by AstraZeneca.
02
Drugs
olaparib
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT2080222063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222063.